Table 1: Demographic and Clinical Characteristics - Rheumatoid_arthritis_&_osteoarthritis
	Total	non-current NSAID use	current NSAID use

1	  561,840 (100.0)	  386,232 (100.0)	  175,608 (100.0)

Grouped age
1	   15,857 (2.8)	   11,460 (3.0)	    4,397 (2.5)
2	   50,552 (9.0)	   34,747 (9.0)	   15,805 (9.0)
3	  140,011 (24.9)	   94,590 (24.5)	   45,421 (25.9)
4	  171,894 (30.6)	  114,867 (29.7)	   57,027 (32.5)
5	  135,845 (24.2)	   94,462 (24.5)	   41,383 (23.6)
6	   47,681 (8.5)	   36,106 (9.3)	   11,575 (6.6)

Male
0	  349,824 (62.3)	  239,185 (61.9)	  110,639 (63.0)
1	  212,016 (37.7)	  147,047 (38.1)	   64,969 (37.0)

Grouped BMI
1	    4,383 (0.8)	    3,173 (0.8)	    1,210 (0.7)
2	  112,731 (20.1)	   81,373 (21.1)	   31,358 (17.9)
3	  186,524 (33.2)	  131,090 (33.9)	   55,434 (31.6)
4	  125,123 (22.3)	   84,553 (21.9)	   40,570 (23.1)
5	   56,541 (10.1)	   36,383 (9.4)	   20,158 (11.5)
6	   30,766 (5.5)	   18,436 (4.8)	   12,330 (7.0)
.	   45,772 (8.1)	   31,224 (8.1)	   14,548 (8.3)

Smoking status
1	  234,265 (41.7)	  164,025 (42.5)	   70,240 (40.0)
2	  252,716 (45.0)	  171,577 (44.4)	   81,139 (46.2)
3	   73,882 (13.2)	   49,954 (12.9)	   23,928 (13.6)
.	      977 (0.2)	      676 (0.2)	      301 (0.2)

Smoking status (missing set to non)
1	  235,242 (41.9)	  164,701 (42.6)	   70,541 (40.2)
2	  252,716 (45.0)	  171,577 (44.4)	   81,139 (46.2)
3	   73,882 (13.2)	   49,954 (12.9)	   23,928 (13.6)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Ethnicity
1	  394,382 (70.2)	  270,045 (69.9)	  124,337 (70.8)
2	    2,969 (0.5)	    2,143 (0.6)	      826 (0.5)
3	   26,934 (4.8)	   19,933 (5.2)	    7,001 (4.0)
4	    8,323 (1.5)	    6,225 (1.6)	    2,098 (1.2)
5	    4,703 (0.8)	    3,464 (0.9)	    1,239 (0.7)
.	  124,529 (22.2)	   84,422 (21.9)	   40,107 (22.8)

Index of Multiple Deprivation (IMD)
1	  113,676 (20.2)	   79,361 (20.5)	   34,315 (19.5)
2	  112,360 (20.0)	   77,545 (20.1)	   34,815 (19.8)
3	  112,815 (20.1)	   77,316 (20.0)	   35,499 (20.2)
4	  111,059 (19.8)	   75,989 (19.7)	   35,070 (20.0)
5	  111,930 (19.9)	   76,021 (19.7)	   35,909 (20.4)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity
1	  476,659 (84.8)	  327,223 (84.7)	  149,436 (85.1)
2	   63,149 (11.2)	   43,688 (11.3)	   19,461 (11.1)
3	   20,732 (3.7)	   14,435 (3.7)	    6,297 (3.6)
4	    1,300 (0.2)	      886 (0.2)	      414 (0.2)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Rheumatoid arthritis/osteoarthritis/both
.	        0 (0.0)	        0 (0.0)	        0 (0.0)
1	   30,211 (5.4)	   17,486 (4.5)	   12,725 (7.2)
2	  511,796 (91.1)	  357,616 (92.6)	  154,180 (87.8)
3	   19,833 (3.5)	   11,130 (2.9)	    8,703 (5.0)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)



Diagnosed hypertension
1	  208,187 (37.1)	  141,971 (36.8)	   66,216 (37.7)

Heart Failure
1	    6,428 (1.1)	    5,020 (1.3)	    1,408 (0.8)

Other Heart Diseases
1	   14,524 (2.6)	   10,316 (2.7)	    4,208 (2.4)

Diabetes
1	   85,181 (15.2)	   59,009 (15.3)	   26,172 (14.9)

COPD
1	   27,370 (4.9)	   18,973 (4.9)	    8,397 (4.8)

Other Respiratory Diseases
1	   11,199 (2.0)	    7,769 (2.0)	    3,430 (2.0)

Cancer
1	   53,890 (9.6)	   37,908 (9.8)	   15,982 (9.1)

Immunosuppressed (combination algorithm)
1	    6,129 (1.1)	    4,167 (1.1)	    1,962 (1.1)

Chronic kidney disease
1	   39,417 (7.0)	   28,246 (7.3)	   11,171 (6.4)

Osteoarthritis
1	  531,629 (94.6)	  368,746 (95.5)	  162,883 (92.8)

Rheumatoid arthritis
1	   50,044 (8.9)	   28,616 (7.4)	   21,428 (12.2)

Flu vaccine
1	  269,442 (48.0)	  182,887 (47.4)	   86,555 (49.3)

Pneumococcal Vaccine
1	   75,116 (13.4)	   50,417 (13.1)	   24,699 (14.1)

Recent Statin
1	  144,320 (25.7)	   97,163 (25.2)	   47,157 (26.9)

Recent PPIs
1	  240,652 (42.8)	  103,240 (26.7)	  137,412 (78.2)

Recent oral prednisolone
1	   24,281 (4.3)	   16,046 (4.2)	    8,235 (4.7)

Recent hydroxychloroquine
1	   10,933 (1.9)	    5,830 (1.5)	    5,103 (2.9)

Recent Other DMARDs use
1	   27,132 (4.8)	   14,433 (3.7)	   12,699 (7.2)

GP consultation in last year (binary)
1	  540,525 (96.2)	  368,334 (95.4)	  172,191 (98.1)

A&E attendance rate in last year (binary)
1	  104,708 (18.6)	   71,744 (18.6)	   32,964 (18.8)

GP consultation count
Median (IQR)	8 (4-13)	8 (4-13)	8 (5-14)
Min, Max	0, 376	0, 376	0, 360
Age (years)
Median (IQR)	64 (55-72)	64 (55-72)	63 (55-71)
Min, Max	18, 110	18, 110	18, 103
A&E attendance count
Median (IQR)	0 (0-0)	0 (0-0)	0 (0-0)
Min, Max	0, 77	0, 77	0, 59

Median (IQR)	105 (105-105)	105 (105-105)	105 (105-105)
Min, Max	1, 105	1, 105	1, 105
